Biolife Solutions (BLFS) Non-Current Deffered Revenue (2010 - 2021)
Biolife Solutions (BLFS) posted quarterly Non-Current Deffered Revenue of $64000.0 for Q1 2021, down 9.86% quarter-over-quarter from $71000.0 in Q4 2020.
Biolife Solutions (BLFS) Non-Current Deffered Revenue (2010 - 2021) Analysis & Trends
Biolife Solutions (BLFS) has reported Non-Current Deffered Revenue for 11 consecutive years, with $64000.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Non-Current Deffered Revenue changed N/A year-over-year to $64000.0; the TTM figure through Mar 2021 stood at $64000.0 (changed N/A YoY), while the FY2020 annual figure was $71000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue declined to $64000.0 in Q1 2021 per BLFS's latest filing, from $71000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $656581.0 in Q3 2017 and bottomed at -$62984.0 in Q1 2017.
- Historically, Non-Current Deffered Revenue has averaged $257346.6 across 4 years, with a median of $349000.0 in 2018.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 2575.45% in 2017 and fell as far as 572.32% in 2017.
- Biolife Solutions' Non-Current Deffered Revenue stood at $492000.0 in 2017, then fell by 29.07% to $349000.0 in 2018, then slumped by 79.66% to $71000.0 in 2020, then decreased by 9.86% to $64000.0 in 2021.
- Business Quant data shows BLFS's Non-Current Deffered Revenue at $64000.0 in Q1 2021, $71000.0 in Q4 2020, and $349000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 64,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Dec 31, 2018 | 349,000.00 |
| Sep 30, 2018 | 386,113.00 |
| Jun 30, 2018 | 422,828.00 |
| Dec 31, 2017 | 492,000.00 |
| Sep 30, 2017 | 656,581.00 |
| Jun 30, 2017 | -62,419.00 |
| Mar 31, 2017 | -62,984.00 |
| Dec 31, 2016 | 27,989.00 |
| Sep 30, 2016 | 24,541.00 |
| Jun 30, 2016 | 19,929.00 |
| Mar 31, 2016 | 13,335.00 |
| Dec 31, 2015 | 914,674.00 |
| Sep 30, 2015 | 29,700.00 |
| Jun 30, 2015 | 21,651.00 |
| Mar 31, 2015 | 4,966.00 |
| Dec 31, 2014 | 874,825.00 |
| Sep 30, 2014 | -18,007.00 |
| Mar 31, 2014 | -5,227.00 |